Clinical trial Recruiting at 57 sites Interventional Ages 18 and up

Comparing axillary radiotherapy and lymphadenectomy in breast cancer patients after neoadjuvant therapy

Official title: Axillary Lymph Node Dissection Versus Axillary Radiotherapy in Breast Cancer Patients With Positive Sentinel Node After Neoadjuvant Therapy: A Multicenter Randomized Study

Run by Hospital Universitari de Bellvitge · NCT04889924 · Data updated 2026-11-12

This study is testing whether using axillary radiotherapy instead of surgery can help breast cancer patients who have had neoadjuvant treatment avoid lymphedema.

More Breast Cancer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment820 (estimated)
SponsorHospital Universitari de Bellvitge
Academic / other
Drugs / interventionschemotherapy
Locations61 sites (Sydney, New South Wales and 60 other locations)
StatusRecruiting
StartedJune 11, 2021
Main results expectedDecember 31, 2026
Study endsDecember 31, 2028
Registry record updatedSeptember 17, 2026
Trial IDNCT04889924 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are breast cancer patients with sentinel node involvement who have received neoadjuvant systemic treatment and meet specific eligibility criteria.

Probably not a fit

Patients with more advanced nodal involvement (cN2) or those who have had prior breast surgery for ipsilateral cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates whether axillary radiotherapy (ART) can reduce the risk of lymphedema compared to axillary lymph node dissection (ALND) in breast cancer patients who have undergone neoadjuvant systemic treatment and have positive sentinel nodes. The study is a prospective, randomized, open-label, multicenter trial with an estimated sample size of 1660 patients over five years. Participants will be stratified based on their neoadjuvant treatment regimen, and both groups will be monitored for recurrence, overall survival, and quality of life. An interim analysis will be conducted after recruiting the first 820 patients to assess early outcomes.

Why it matters

Potential benefit: If successful, this study could provide a less invasive treatment option that minimizes the risk of lymphedema for breast cancer patients.

How similar studies have gone: Previous studies have shown that omitting axillary lymph node dissection can reduce lymphedema risk, but this specific approach in the context of neoadjuvant therapy is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* T1-T4 N0/ T0-T4 N1 at diagnosis and subsidiary of neoadjuvant treatment
* Post-CT SLN with ≤2 macrometastasis/micrometastasis or ITCs
* Post-CT axillary response by ultrasound or MRI
* Complete at least 70% of neoadjuvant chemotherapy and 6 months of endocrine treatment.

Exclusion Criteria:

* cN2
* ypN0
* History of breast surgery for ipsilateral cancer in the last 10 years
* History of other cancer in the last 5 years, except squamous carcinoma of the skin.

Where it's running

  • GenesisCare Mater
    Sydney, New South Wales, Australia
    Recruiting
  • GenesisCare North Shore
    Sydney, New South Wales, Australia
    Recruiting
  • GenesisCare Frenchs Forest
    Sydney, New South Wales, Australia
    Recruiting
  • GenesisCare Norwest
    Sydney, New South Wales, Australia
    Recruiting
  • GenesisCare Hurstville
    Sydney, New South Wales, Australia
    Recruiting
  • GenesisCare Campbelltown
    Sydney, New South Wales, Australia
    Recruiting
Show 44 more locations
  • Hospital Universitari Germans Trias i Pujol
    Badalona, Barcelona, Spain
    Recruiting
  • Instituto Catalán de Oncología de Badalona
    Badalona, Barcelona, Spain
    Recruiting
  • Hospital Comarcal Sant Jaume de Calella
    Calella, Barcelona, Spain
    Recruiting
  • Hospital General de Granollers
    Granollers, Barcelona, Spain
    Recruiting
  • Consorci Sanitari Integral
    L'Hospitalet de Llobregat, Barcelona, Spain
    Recruiting
  • Hospital Universitario de Bellvitge
    L'Hospitalet de Llobregat, Barcelona, Spain
    Recruiting
  • Instituto Catalán de Oncología- Hospital Duran i Reynals
    L'Hospitalet de Llobregat, Barcelona, Spain
    Recruiting
  • Fundación Althaia Manresa
    Manresa, Barcelona, Spain
    Recruiting
  • Hospital de Mataró
    Mataró, Barcelona, Spain
    Recruiting
  • Hospital Universitario Mútua Terrassa
    Terrassa, Barcelona, Spain
    Recruiting
  • Consorci Sanitari de Terrassa
    Terrassa, Barcelona, Spain
    Recruiting
  • Hospital de Viladecans
    Viladecans, Barcelona, Spain
    Recruiting
  • Hospital Universitario de Cruces
    Barakaldo, Bizkaia, Spain
    Recruiting
  • Hospital Universitario Galdakao-Usansolo
    Galdakao, Bizkaia, Spain
    Recruiting
  • Hospital Universitario de Donostia
    Donostia / San Sebastian, Gipuzkoa, Spain
    Recruiting
  • Hospital Universitario Príncipe de Asturias
    Alcalá de Henares, Madrid, Spain
    Recruiting
  • Hospital Universitario Severo Ochoa
    Leganés, Madrid, Spain
    Recruiting
  • Hospital Universitario Puerta De Hierro
    Majadahonda, Madrid, Spain
    Recruiting
  • Hospital Universitario Infanta Cristina
    Parla, Madrid, Spain
    Recruiting
  • Hospital Clínico Universitario Virgen de la Arrixaca
    El Palmar, Murcia, Spain
    Recruiting
  • Hospital Ribera Povisa
    Vigo, Pontevedra, Spain
    Recruiting
  • Hospital Álvaro Cunqueiro
    Vigo, Pontevedra, Spain
    Recruiting
  • Hospital Universitario de Canarias
    San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain
    Recruiting
  • Hospital Universitario Sant Joan de Reus
    Reus, Tarragona, Spain
    Recruiting
  • Hospital Universitario de A Coruña
    A Coruña, Spain
    Recruiting
  • Hospital del Mar
    Barcelona, Spain
    Recruiting
  • Hospital de la Santa Cruz y San Pablo
    Barcelona, Spain
    Recruiting
  • Hospital Clínico y Provincial de Barcelona
    Barcelona, Spain
    Recruiting
  • Hospital Universitario de Burgos
    Burgos, Spain
    Recruiting
  • Hospital Universitario de Gerona Doctor Josep Trueta
    Girona, Spain
    Recruiting
  • Institut Catalán de Oncología de Girona
    Girona, Spain
    Recruiting
  • Hospital Universitario Virgen de las Nieves
    Granada, Spain
    Recruiting
  • Hospital General Universitario Gregorio Marañón
    Madrid, Spain
    Recruiting
  • Hospital Universitario Ramón y Cajal
    Madrid, Spain
    Recruiting
  • Hospital Universitario 12 de Octubre
    Madrid, Spain
    Recruiting
  • Hospital Universitario La Paz
    Madrid, Spain
    Recruiting
  • Hospital Universitario HM Sanchinarro
    Madrid, Spain
    Recruiting
  • Hospital Universitario Infanta Sofía- Fundación de Inv. Biomédica H. Infanta Sofía
    Madrid, Spain
    Recruiting
  • Hospital Regional Universitario de Málaga
    Málaga, Spain
    Recruiting
  • Hospital Universitario Virgen de la Victoria
    Málaga, Spain
    Recruiting
  • Hospital Universitario de Navarra
    Pamplona, Spain
    Recruiting
  • Hospital Montecelo
    Pontevedra, Spain
    Recruiting
  • Hospital Universitario Nuestra Señora de Candelaria
    Santa Cruz de Tenerife, Spain
    Recruiting
  • Hospital General de Segovia
    Segovia, Spain
    Recruiting

+11 more sites. See ClinicalTrials.gov for the full list.

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.